Video: Latest Treatment for Hep C.

Diphenhydramine / hydrocortisone topical Pregnancy and Breastfeeding Warnings

Diphenhydramine / hydrocortisone topical is also known as: HC-Derma-Pax

Diphenhydramine / hydrocortisone topical Pregnancy Warnings

Systemic diphenhydramine has been assigned to pregnancy category B by the FDA. Systemic hydrocortisone has not been assigned to an FDA pregnancy category. Animal studies on systemic diphenhydramine have failed to reveal teratogenicity. One study reported a statistical relationship between diphenhydramine use in the first trimester and cleft palate. One case of withdrawal in an infant whose mother ingested 150 mg per day of diphenhydramine has been reported. This infant developed tremor on the fifth day of life which was treated with phenobarbital. Animal studies involving corticosteroids have revealed evidence of an increased incidence of cleft palate in offspring. There are no controlled data in human pregnancy, however, corticosteroids have been used during human pregnancy without evidence of teratogenicity.

Diphenhydramine-hydrocortisone topical has not been formally assigned to a pregnancy category by the FDA. Animal studies on diphenhydramine-hydrocortisone topical have not been reported. There are no controlled data in human pregnancy. Diphenhydramine-hydrocortisone topical should only be given during pregnancy when benefits outweigh risks.

Diphenhydramine / hydrocortisone topical Breastfeeding Warnings

There are no data on the excretion of diphenhydramine-hydrocortisone topical into human milk. Systemic diphenhydramine is excreted into human milk. Systemic diphenhydramine may also inhibit lactation. The manufacturer of systemic diphenhydramine recommends that due to the potential for serious adverse reactions in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother. There are no data on the excretion of hydrocortisone into human milk. Some corticosteroids are excreted into human milk in small amounts. The manufacturer of systemic hydrocortisone recommends against the use of pharmacologic doses of hydrocortisone by nursing women.

See Also...

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.

Hide
(web4)